Details for New Drug Application (NDA): 016776
✉ Email this page to a colleague
NDA 016776 describes SORBITRATE, which is a drug marketed by Astrazeneca and is included in six NDAs. Additional details are available on the SORBITRATE profile page.
The generic ingredient in SORBITRATE is isosorbide dinitrate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
The generic ingredient in SORBITRATE is isosorbide dinitrate. There is one drug master file entry for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.
Summary for 016776
| Tradename: | SORBITRATE |
| Applicant: | Astrazeneca |
| Ingredient: | isosorbide dinitrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016776
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 5MG | ||||
| Approval Date: | Apr 1, 1996 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET, CHEWABLE;ORAL | Strength | 10MG | ||||
| Approval Date: | Apr 1, 1996 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
